Real-time enrollment status for this congenital hyperinsulinism clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 10:16 AM UTC
| NCT Number | NCT04732416 |
| Recruiting Status | Recruiting |
| Condition | Congenital Hyperinsulinism |
| Phase | Clinical Trial |
| Target Enrollment | 16 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Hanmi Pharmaceutical Company Limited |
| Last Updated on CT.gov | February 21, 2025 (Feb 21, 2025) |
As of March 2, 2026: Clinical trial NCT04732416 is currently recruiting participants. This clinical trial study for congenital hyperinsulinism is actively seeking new participants at 2 locations across the United States. The study is sponsored by Hanmi Pharmaceutical Company Limited. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04732416 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04732416 was last updated Feb 21, 2025 (February 21, 2025). HelloStudys verifies this status automatically.